Efficacy of melbine combined with clomifene citrate in treatment of patients with polycystic ovarian syndrome
- VernacularTitle:二甲双胍联合枸橼酸氯米芬治疗多囊卵巢综合征患者疗效观察
- Author:
Haiying LIU
;
Jinxia LI
;
Peng HAN
- Publication Type:Journal Article
- Keywords:
polycystic ovary syndrome;
melbine;
clomiphene citrate;
ovulation induction
- From:
Chinese Journal of Biochemical Pharmaceutics
2015;(3):147-149
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the efficacy of melbine combined with clomifene citrate in treatment of patients with polycystic ovarian syndrome ( PCOS) .Methods 60 patients aged 20 to 39 with PCOS were randomly divided into observation group and control group, 30 patients in each group.In the menstrual cycle of 3~7 d, the control group received clomifene citrate orally (50 mg per time, qd), and the observation group received melbine (2.5 mg per time, qd)combined with clomifene citrate (50 mg per time, qd), with a course of 5 days.Results The number of mature follicles and score of cervical mucus in obsercation group was significant higher than that in control group, respectively(P<0.05).The rate of follicular development and ovulation rate of single follicle in obsercation group was significant higher than that in control group, respectively(P<0.05), but there were no significant differences of pregnancy rate, first trimester abortion rate and periodic ovulation rate between two groups.The rate of endometrial thickness<7 mm patients in observation group was significantly lower and positive rate of three line was higher than that in control group, respectively ( P<0.05).The follicle stimulating hormone level in observation group was significantly lower than that in control group(P<0.05), but there was no significant difference of luteinizing hormone between two groups.Conclusion Melbine combined with clomifene citrate has a good effect on mature follicles number and endometrial thickness in anovulatory infertility women caused by polycystic ovary syndrome.
